The adaptor protein Gads is a Grb2-related protein originally identified on the basis of its interaction with the tyrosine-phosphorylated form of the docking protein Shc. Gads protein expression is restricted to hematopoietic tissues and cell lines. Gads contains a Src homology 2 (SH2) domain, which has previously been shown to have a similar binding specificity to that of Grb2. Gads also possesses two SH3 domains, but these have a distinct binding specificity to those of Grb2, as Gads does not bind to known Grb2 SH3 domain targets. Here, we investigated whether Gads is involved in T-cell signaling.
Background
The engagement of the T-cell receptor (TCR)-CD3 complex activates the Src-family tyrosine kinases p56 lck and p59 fyn which rapidly phosphorylate immunoreceptor tyrosine-based activation motif (ITAM) sequences found in the intracellular domains of the CD3 chains [1] [2] [3] [4] . Phosphorylation of the tyrosine residues in the CD3ζ chain ITAMs establishes a binding site for the tandem Src homology 2 (SH2) domain-containing protein tyrosine kinase ZAP-70 [5] [6] [7] [8] [9] . ZAP-70 is subsequently tyrosinephosphorylated by p56 lck , which leads to the upregulation of ZAP-70 kinase activity [10, 11] . Activated Src-family tyrosine kinases and ZAP-70 tyrosine kinases phosphorylate downstream substrates, such as phospholipase Cγ1 (PLCγ1) [12] , the proto-oncogene Vav [13] , Cbl [14] , SLP-76 [15] , and LAT (linker for activation of T cells) [16] [17] [18] [19] , thereby initiating signaling cascades that culminate in the activation of cytokine gene transcription through the activation of transcription factors such as nuclear factor of activated T cells (NFAT) [1] [2] [3] [4] .
These complex signaling pathways require the assembly of multiprotein complexes through adaptor molecules such as SLP-76 and LAT [20] . Both of these proteins assemble phosphorylation-dependent and phosphorylation-independent signaling complexes through their interaction with enzymes and adaptor proteins that contain SH2 and SH3 domains. The hematopoietic-specific adaptor protein SLP-76 was originally identified as a tyrosine-phosphorylated protein in activated T cells that interacts in vitro with a recombinant form of the Grb2 adaptor protein [15] . Overexpression of SLP-76 in T cells has been demonstrated to enhance both TCR-mediated extracellular-signal-regulated kinase (ERK) activation, and NFAT-mediated activation of the interleukin-2 (IL-2) promoter and the NFAT response element, suggesting a function for SLP-76 in coupling proximal signaling events with distal transcriptional events [21] [22] [23] . Recently, Clements et al. [24] and Pivniouk et al. [25] reported that SLP-76-deficient mice lack peripheral T cells due to a block in thymic development at the stage when pre-TCR signaling begins (that is, when thymocytes express neither the CD4 or CD8 cell-surface markers and are classed as 'double-negative'), demonstrating an essential role for SLP-76 in signaling from the pre-TCR during normal T-cell development. In addition, experiments with a SLP-76-deficient Jurkat T-cell line have shown that the tyrosine phosphorylation of PLCγ1, activation of ERK and calcium mobilization all require SLP-76 function, suggesting that SLP-76 is required to achieve sufficient activation of both the Ras-dependent and calcium-dependent T-cell signaling pathways [26] . Presumably SLP-76 modulates these pathways via its interaction with additional signaling proteins such as Vav, Grb2 and SLAP-130/FYB [15, [27] [28] [29] . The mechanism by which SLP-76 is coupled to the TCR and how it acts to modulate multiple pathways is not clear, however.
The recently cloned membrane-associated protein pp36 LAT is highly phosphorylated on tyrosine residues following TCR engagement [18, 19] . LAT possesses several tyrosine residues within consensus binding sites for the SH2 domains of Grb2 and PLCγ1 [19] . It has been proposed that the tyrosine phosphorylation of LAT initiates both Ras-dependent and calcium-dependent signaling pathways through the recruitment of the complex of Grb2 and the Sos guanine nucleotide exchange factor, and of PLCγ1, respectively [16, 19, 30] .
Grb2 is a small adaptor protein composed of one SH2 and two flanking SH3 domains, and has been shown to link activated growth factor receptors to Ras activation through its interaction with Sos [31] [32] [33] . Growth-factor-dependent receptor activation and autophosphorylation, or tyrosine phosphorylation of docking proteins such as Shc, generates specific binding sites for the SH2 domain of Grb2. The Grb2 SH3 domains mediate the stable association with proline-based motifs in Sos, thereby recruiting Sos to the receptor complex following activation. In T cells, Grb2 is also associated with Sos [30, 34] , and various models have been proposed for SH2-domain-mediated Grb2-Sos translocation to the membrane, such as TCR-Shc-mediated recruitment [35] or, as more recently proposed, recruitment of Grb2-Sos by the membrane-associated LAT protein [16] [17] [18] [19] . Grb2 has also been demonstrated to associate via its SH3 domains with Cbl and SLP-76 [36] , suggesting that Grb2 may couple the TCR to pathways other than Ras. Whether Grb2 association with these additional SH3-domain-binding proteins is of functional importance in TCR signaling has not been elucidated.
The adaptor protein Gads (Grb2-related adaptor downstream of Shc) was originally identified as a Grb2-related protein that interacts with tyrosine-phosphorylated Shc [37] . The Gads SH2 domain appears to have a similar binding specificity to that of Grb2 and the related protein Grap (Grb2-related adaptor protein) [38, 39] , binding to Shc and the Bcr-Abl fusion protein, but displays a distinct SH3-domain-binding specificity. On the basis of the observation that Gads does not bind to Sos or other known Grb2 SH3 domain targets, Gads has been proposed to couple common upstream tyrosine-phosphorylated proteins to novel downstream targets. In this report, we demonstrate that Gads is highly expressed in T cells and binds to two important components of TCR signaling -LAT and SLP-76.
Furthermore, we have found that SLP-76 and Gads act synergistically to augment NFAT activation. These results suggest that Gads plays an important role in T-cell signaling through its association with SLP-76 and LAT.
Results

Gads is expressed in hematopoietic cells
We have previously determined by northern blot analysis that Gads expression is largely restricted to hematopoietic tissues and that Gads is abundantly expressed in both murine CTLL2 and human Jurkat, MOLT4 and K562 cells [37] . To determine whether the Gads protein is expressed in additional hematopoetic lineages, primary hematopoietic cells or hematopoietic cell lines were lysed and subjected to immunoprecipitation with anti-Gads antibodies, followed by immunoblotting with anti-Gads antibodies. As previously observed, Gads was highly expressed in Jurkat T cells and, in addition, was detected in the MO7E megakaryocytic cell line, as well as in both primary bone-marrow-derived mast cells and primary T cells. Gads expression was undetectable in HCD-57 erythroid, P815 mastocytoma, or Raji B lymphoblast cell lines ( Figure 1 ). In addition, Gads expression was detected in natural killer (NK) and macrophage cell lines by immunoprecipitation with anti-Gads antibodies (our unpublished observations). These results suggest that Gads expression is restricted to T lymphocytes, megakaryocytes, mast cells, NK cells and macrophages.
Gads is associated with tyrosine-phosphorylated SLP-76 and LAT following TCR stimulation
As Gads is most highly expressed in both primary T cells and T-cell lines, we were interested in examining a possible role for Gads in T-cell signaling. Lysates from Human Gads unstimulated or anti-CD3-stimulated Jurkat T cells were subjected to immunoprecipitation with anti-Gads antibody, and the presence of phosphotyrosine-containing proteins in the immunoprecipitates was assessed by antiphosphotyrosine immunoblotting. A coimmunoprecipitating tyrosine-phosphorylated protein of 76 kDa was detected prior to anti-CD3 stimulation, and additional 36 kDa and 42 kDa phosphoproteins appeared after stimulation in the anti-Gads immunoprecipitates but not in control immunoprecipitations using rabbit anti-mouse IgG or protein A alone (Figure 2a) . Increased tyrosine phosphorylation of the 76 kDa protein was observed following anti-CD3 stimulation (Figure 2a) . Similarly, a predominant tyrosine-phosphorylated protein of 76 kDa coimmunoprecipitated with Gads after anti-CD3 crosslinking of primary murine lymphocytes (Figure 2a) .
To identify the tyrosine-phosphorylated proteins associated with Gads, anti-Gads immunoprecipitations were performed using unstimulated and anti-CD3-stimulated Jurkat T-cell lysates, and the immunoprecipitates were immunoblotted with antibodies against known proteins of the corresponding molecular weights. Anti-SLP-76 antibodies recognized the 76 kDa protein in anti-Gads immunoprecipitates from both unstimulated and stimulated lysates ( Figure 2b ). Similarly, Gads protein was detected in anti-SLP-76 immunoprecipitates from both unstimulated and stimulated Jurkat cells by anti-Gads immunoblotting. In agreement with previous reports, a complex between endogenous Grb2 and SLP-76 was not detected ( Figure 2b ). As SLP-76 was originally identified as a Grb2-binding protein, we asked whether another major Grb2-binding protein -Sos -was associated with Gads in Jurkat T cells. No Sos-immunoreactive bands were detected in anti-Gads immunoprecipitates, whereas Sos was clearly present in anti-Grb2 immunoprecipitates from the same experiment ( Figure 2c ). These results suggest that the binding specificities of Grb2 and Gads are not entirely the same.
Anti-LAT antibodies detected a 36 kDa protein only in anti-Gads immunoprecipitates from stimulated lysates (Figure 2d ). Stripping the blot and reprobing with antiphosphotyrosine antibodies verified that SLP-76-immunoreactive and LAT-immunoreactive bands corresponded to the respective 76 kDa and 36 kDa tyrosine-phosphorylated proteins previously detected in antiGads immunoprecipitates (data not shown). Together, these experiments indicate that SLP-76 is constitutively associated with Gads, whereas the association of LAT with Gads occurs following TCR ligation.
Mapping of the Gads domains required for interaction with SLP-76 and LAT
To define the region of Gads that interacts with SLP-76, recombinant full-length glutathione S-transferase (GST)-Gads fusion proteins containing inactivating point mutations in the SH3 or SH2 domains [37] were assessed for their ability to interact with tyrosine-phosphorylated proteins from anti-CD3 stimulated Jurkat T-cell lysates (Figure 3a) . The major tyrosine-phosphorylated protein corresponding to SLP-76 was not precipitated by the GST-Gads mutant proteins in which both SH3 domains or the carboxy-terminal SH3 domain alone were inactivated, suggesting that the carboxy-terminal SH3 domain is required for the interaction between Gads and SLP-76. GST-Gads mutant proteins with an inactivated SH2 domain did not precipitate the 36 kDa tyrosine-phosphorylated protein corresponding to LAT, demonstrating that the Gads-LAT interaction requires a functional Gads SH2 domain. No change in the profile of tyrosine-phosphorylated proteins bound by a Gads mutant with an inactivating mutation in the amino-terminal SH3 domain was observed (Figure 3a) . These results were supported by the observation that GST fusion proteins consisting of the isolated Gads carboxy-terminal SH3 domain and SH2 domain were sufficient for binding to SLP-76 and LAT, respectively, from anti-CD3 stimulated Jurkat T-cell lysate (data not shown).
To confirm these results in vivo, Jurkat T cells were transiently transfected with cDNAs encoding FLAG-epitopetagged wild-type Gads or Gads mutants with inactivated SH3 or SH2 domains. FLAG immunoprecipitations from unstimulated and anti-CD3-stimulated cells were subsequently assayed for the presence of coprecipitating SLP-76 and LAT. Consistent with the results obtained in vitro, inactivation of the Gads SH3 domains abrogated the in vivo association between Gads and SLP-76, whereas inactivation of the Gads SH2 domain resulted in a loss of LAT association in vivo (Figure 3b ).
The 224-244 amino-acid region of SLP-76 is required for binding to Gads
As the Gads carboxy-terminal SH3 domain was responsible for mediating the interaction with SLP-76, we tested whether sequences within the proline-rich region of SLP-76 contained the binding site. Recombinant GST fusion proteins containing various regions of the proline-rich domain of SLP-76 were incubated with Jurkat T-cell lysates and immunoblotted for the presence of Gads (Figure 4a ). GST fusion proteins corresponding to amino acids 225-265 or 225-275 of SLP-76 were able to precipitate Gads, whereas fusion proteins containing regions carboxy-terminal to amino acid 235 did not precipitate Gads. This suggests that the Gads-binding site resides between amino acids 225-235. To determine whether this region is required for interaction with Gads in vivo, transient transfection of cDNAs corresponding to FLAGtagged wild-type SLP-76 or a FLAG-tagged SLP-76 mutant lacking amino acids 224-244 were performed in Jurkat T cells, and the interaction of the FLAG-tagged SLP-76 with endogenous Gads was assessed (Figure 4b ). Unlike wild-type SLP-76, the mutant SLP-76 was unable to coimmunoprecipitate Gads, indicating that the 224-244 amino-acid region of SLP-76 is responsible for interacting with Gads in vivo. Deletion of amino acids 1-156 of SLP-76, a region that contains the major sites of tyrosine phosphorylation, had no effect on Gads binding.
Gads synergizes with SLP-76 to augment NFAT activity
Transcription of the IL-2 gene following TCR ligation is an essential component of the T-cell activation process. This event is mediated in part by the activation and binding of the NFAT transcription factor to the IL-2 promoter. The transient overexpression of SLP-76 has been previously demonstrated to enhance transcription of a luciferase reporter gene driven by the NFAT-binding region of the IL-2 promoter in response to TCR ligation [22] . On the basis of the observation that SLP-76 is a major binding partner for Gads, we examined whether Gads may be involved in a signaling pathway coupling TCR activation to the distal activation of NFAT and IL-2. To explore this possibility, Jurkat T cells were transiently cotransfected with a reporter plasmid containing the luciferase gene driven by the IL-2 NFAT-binding site together with FLAG-tagged Gads and/or FLAG-SLP-76 expression constructs (Figure 5a ). Overexpression of wild-type Gads Gads did not appear to influence activation of the NFAT-driven reporter gene following stimulation with either anti-TCR antibodies or anti-TCR antibodies plus phorbol myristate acetate (PMA); wild-type SLP-76 overexpression resulted in enhanced NFAT activation as previously reported [22] . Coexpression of both SLP-76 and wild-type Gads resulted in the synergistic activation of NFAT (Figure 5a ), suggesting that Gads functions in concert with SLP-76 to activate NFAT. This synergistic influence of Gads and SLP-76 coexpression was also observed using a luciferase reporter gene driven by the full-length IL-2 promoter (Figure 5b) . A functional SH2 domain was essential for Gads to synergize with SLP-76 because the Gads SH2 mutant (SH2*) failed to augment, and in fact appeared to inhibit, NFAT activation when transiently expressed either alone or in combination with SLP-76 ( Figure 5c ).
Discussion
Several adaptor proteins have been shown to play an essential role in coupling membrane proximal events following TCR ligation to downstream signaling pathways. The membrane-anchored LAT adaptor protein is believed to provide a route to Ras activation through the recruitment of Grb2-Sos and Grap-Sos complexes [16, 19, 38] and to initiate calcium-dependent signals through its association with PLCγ. The SH2 and SH3 domains of both Grb2 and Grap adaptor proteins have overlapping binding specificities and accordingly have been demonstrated to associate with common proteins such as LAT, Sos, Cbl and dynamin [19, 38, 39] . Their overlapping binding specificities have led to the hypothesis that Grb2 and Grap may serve to amplify common signaling pathways following TCR engagement [38] . In this report, we have explored the function of a new Grb2-related adaptor protein, Gads, in T cells. Gads does not interact with Sos but rather associates with the hematopoietic-specific proteins LAT and SLP-76, suggesting that Gads may have a specific role in TCR signaling, distinct from that of Grb2 or Grap. In addition, our study provides evidence for the relevance of Gads in TCR signaling, because we found that Gads and SLP-76 synergize to augment TCR-mediated NFAT and IL-2 gene activation.
We have previously reported that, although the binding specificity of the Gads SH2 domain is similar to that of the Grb2 SH2 domain, the binding specificity of the Gads SH3 domain appears to be distinct [37] . In Jurkat T cells, we have found that Gads is constitutively associated with SLP-76, while inducibly associating with LAT following TCR ligation. The interaction between Gads and LAT is mediated through the Gads SH2 domain. LAT possesses five tyrosine residues which, if phosphorylated, conform to the consensus binding motif (pYXNX; where X represents any amino acid and pY represents a phosphorylated tyrosine residue) for the Grb2 SH2 domain. Two of these sites (Y171 and Y191) have been shown to be critical for association with Grb2 [19] . On the basis of the previously demonstrated binding specificity of the Gads SH2 domain, we postulate that Gads may bind to some of the predicted Grb2-binding sites in LAT.
The constitutive interaction between Gads and SLP-76 was mapped to the carboxy-terminal SH3 domain of Gads, and a 20 amino-acid proline-rich sequence within SLP-76 (amino acids 224-244). Although this region does not contain either a class I (RXXPPXP) or class II (XPPXPXR) consensus SH3-domain-binding motif (in single-letter amino-acid code where X represents any amino acid) [40] , it is equivalent to the region that has been shown to bind to the Grb2 SH3 domain [15, 22] . Studies are currently underway to determine which amino acids in this region constitute the Gads SH3-domainbinding motif. The mapping of the SH3-domain-binding sites of both Gads and Grb2 to the same region of SLP-76 suggests that Gads and Grb2 could compete for binding to SLP-76. Whereas a Gads-SLP-76 complex can readily be detected in vivo, a Grb2-SLP-76 complex has been much more difficult to detect, suggesting that Gads is a physiologically relevant SLP-76-binding protein and is more abundantly found in a complex with SLP-76 in Jurkat T cells. One possible explanation for this is the broader SH3-domain-binding specificity of Grb2, which would also promote its interaction with additional high-affinity SH3-domain ligands in T cells -such as Sos and Cbland reduce the pool of Grb2 bound to SLP-76. In keeping with our previous observations in the K562 leukemia cell line [37] , the binding specificity of the Gads SH3 domains in T cells also appears to be restricted, because SLP-76 is the only phosphoprotein detected which requires an intact Gads SH3 domain, and we have verified that Sos does not bind Gads. The structural basis for the binding selectivity of the SH3 domain of Gads is currently under investigation. An additional question that remains is the identification of targets for the Gads amino-terminal SH3 domain, as we have not detected any proteins that require this domain for their interaction with Gads.
Two major tyrosine-phosphorylated proteins of 62 kDa and 130 kDa have been reported to associate with the SH2 domain of SLP-76 following TCR engagement [22] . Although the identity of the 62 kDa phosphoprotein remains elusive, the 130 kDa phosphoprotein has been cloned and termed SLAP-130/FYB [29, 41] . SLAP-130 is rapidly tyrosine-phosphorylated following TCR stimulation and, aside from an SH3-like domain at its carboxyl terminus, shows no homology to any known proteins [29, 41] . The function of SLAP-130 in TCR signaling is not clear at this time. We have not detected the presence of tyrosinephosphorylated 62 kDa or 130 kDa proteins in anti-Gads immunoprecipitates following TCR stimulation, although tyrosine-phosphorylated SLP-76 is abundantly present (data not shown). This finding suggests that there may be distinct pools of SLP-76 bound to either SLAP-130 or Gads. In addition, the proto-oncogene Vav has been reported to interact with tyrosine phosphorylated SLP-76 [27, 28] ; however, we did not detect a Vav-SLP-76-Gads complex by anti-Vav immunoblotting of anti-Gads immunoprecipitates following TCR crosslinking (data not shown).
Overexpression of SLP-76 has been shown to augment NFAT and IL-2 activation in response to TCR ligation [22] . This effect is probably due to its role both in PLCγ1-mediated calcium mobilization and in ERK activation [26] . SLP-76 may therefore function to integrate the activation of multiple signals from the TCR. We observed that overexpression of wild-type Gads alone has no effect on NFAT activation but, in combination with overexpression of SLP-76, can enhance both NFAT and IL-2 activation. The simplest interpretation of our results is that Gads functions to couple SLP-76 to LAT, thereby promoting cross-talk between these two signaling complexes and activation of downstream signaling pathways.
Our results show that mutation of the Gads SH2 domain abrogates the ability of Gads to bind to LAT and to synergize with SLP-76. In fact, the Gads SH2-domain mutant appears to have an inhibitory effect on SLP-76, perhaps functioning in a dominant-negative fashion because it would still interact effectively with SLP-76 while uncoupling SLP-76 from LAT and other potential SH2 domain targets.
Gads was originally identified in a search for new proteins associated with tyrosine-phosphorylated Shc [37] . We have previously shown an in vivo association between Gads and tyrosine-phosphorylated Shc in K562 leukemic cells, although we have not detected this interaction in the context of activated Jurkat T cells. This is consistent with previous reports that have failed to detect tyrosine phosphorylation of Shc or the formation of Shc-Grb2 complexes in Jurkat T cells and primary human T lymphocytes [30, 42] . This does not preclude a functionally relevant interaction between Shc and Gads in other hematopoietic cell types or in alternative T-cell systems where Shc has been shown to be robustly tyrosine phosphorylated and Shc-Grb2 complexes have been detected [35] .
We have shown that Gads is also expressed in the MO7E megakaryocytic cell line, primary mast cells, NK cells and macrophages, a pattern of expression that coincides with the reported expression pattern of SLP-76 [15, 43, 44] . It is therefore likely that a Gads-SLP-76 complex may be important in signaling from activated receptors in these additional hematopoietic lineages. Tyrosine-phosphorylated Shc or activated receptors such as c-Kit are potential targets of the Gads SH2 domain in these additional cell lineages.
Conclusions
We have demonstrated a role for the hematopoietic-specific adaptor protein Gads in TCR signaling through an SH3-domain-mediated interaction with SLP-76. Gads synergizes with SLP-76 to augment NFAT activation, and a functional SH2 domain is important for mediating this effect. As one of the proteins that binds to the SH2 domain of Gads has been identified as LAT, we propose a model whereby Gads functions to promote cross-talk between the LAT and SLP-76 signaling complexes. Given their overlapping expression patterns, we anticipate a role for Gads-SLP-76 complexes in additional hematopoietic lineages.
Materials and methods
Plasmids
Wild-type SLP-76, SLP-76 mutants and SLP-76 proline-rich GST fusion constructs have been previously described [21] [22] [23] . Wild-type Gads and Gads mutants were previously described in Liu and McGlade [37] , and subcloned in-frame with the FLAG epitope of the modified pEFBOS vector (pEF-FLAG) [21] . The NFAT-driven luciferase reporter vector was provided by J. Crabtree (Stanford University), and the IL-2 promoterdriven luciferase reporter vector was a gift of R. Abraham (Mayo Clinic).
Cell culture
Jurkat and Raji cells were cultured in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum (Gibco BRL), 200 mM L-glutamine, 5 U/ml penicillin C and 5 mg/ml streptomycin sulfate. P815 cells were maintained in DMEM medium supplemented as above. HCD-57 cells were maintained in Iscove's media supplemented with 20% (v/v) fetal bovine serum, 200 mM L-glutamine, 5 U/ml penicillin C, 5 mg/ml streptomycin sulfate and 0.5 U/ml erythropoietin. MO7E cells were maintained in RPMI 1640 medium supplemented with 20% (v/v) fetal bovine serum, 200 mM L-glutamine, 5 U/ml penicillin C, 5 mg/ml streptomycin sulfate and 100 U/ml GM-CSF. Primary mast cells were isolated from murine bone marrow and cultured as previously described in Reith et al. [45] .
Preparation of GST fusion proteins
Recombinant GST fusion proteins were expressed and purified as previously described [46] . Purified proteins bound to glutathione-Sepharose 4B beads (Pharmacia) were resuspended in an equal volume of NP-40 lysis buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 2 mM EDTA, 100 mM ZnCl 2 , 1% (v/v) Nonidet-P40, 10% (v/v) glycerol) containing Complete protease inhibitors (Boehringer-Mannheim) and 1 mM DTT and stored at -80°C. Each of the purified GST fusion proteins was quantitated by SDS-PAGE followed by Coomassie staining, and comparison with BSA standards.
Transient transfections and luciferase reporter assays
For transient transfections, 2 × 10 7 Jurkat T cells were electroporated with 80 µg of the indicated plasmids in serum-free RPMI 1640 with a Gene Pulser (Bio Rad) set at 250 V and 960 µF. Jurkat T cells were harvested 24 h later and processed as described below. For transient transfection in luciferase assays, 1 × 10 7 Jurkat T cells were electroporated with 20 µg IL-2-luciferase or NFAT-luciferase reporter construct, together with 40 µg empty pEF-FLAG vector or pEF-FLAG-SLP-76 and/or pEF-FLAG-Gads vector, as indicated in each experiment. Triplicates of 5 × 10 6 viable cells were stimulated 24 h after transfection, as indicated, for 8 h at 37°C, lysed and luciferase activity quantitated with a luminometer as previously described [21] .
Antibodies
Affinity-purified polyclonal anti-Gads antibodies were described previously [37] . The monoclonal anti-phosphotyrosine antibody 4G10 (Upstate Biotechnology) was used at a dilution of 1:1000 for western blot analysis. Anti-human SLP-76 polyclonal antisera [22] was used at a 1:500 dilution for western blotting and 5 µg were used for immunoprecipitations. Affinity-purified polyclonal anti-LAT antibodies were purchased from Upstate Biotechnology and used for western blotting at a dilution of 1:250. Anti-Sos1 polyclonal antibodies were purchased from Santa Cruz Biotechnology with 4 µg used for immunoprecipitations and a dilution of 1:250 for western blotting. For immunoprecipitations, 4 µg polyclonal anti-Grb2 antibodies (Santa Cruz Biotechnology) were used and a 1:1000 dilution of monoclonal anti-Grb2 antibodies (Transduction Laboratories) used for immunoblotting. In immunoprecipitations, 5 µg monoclonal anti-FLAG M2 antibodies (Kodak) were used and a 1:1000 dilution used for western blotting. Rabbit anti-mouse IgG antibodies were purchased from Upstate Biotechnology and 4 µg used in immunoprecipitations.
Immunoprecipitation and western blotting
For experiments utilizing Jurkat T cells, between 2 and 5 × 10 7 Jurkat T cells were resuspended in 500 µl RPMI 1640 medium, prewarmed at 37°C for 10 min, then left unstimulated or stimulated with 10 µg soluble anti-CD3ε antibody (UCHT1; Pharmingen) for 2 min at 37°C. Then 700 µl chilled phosphate-buffered saline (pH 7.2) containing phosphatase inhibitors (10 mM Na 4 P 2 O 7 , 100 mM NaF, 1 mM Na 3 VO 4 ) was added, and the cells collected by centrifugation, lysed and processed as detailed below. Primary murine T cells were freshly isolated from lymph nodes and stimulated with soluble anti-CD3ε antibody (20 µg/ml, clone 145-2C11, hamster IgG; PharMingen) for 2 min at 37°C. Cells were collected by centrifugation and lysed in 1 ml PLC lysis buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 1.5 mM MgCl 2 , 1 mM EDTA, 10 mM Na 4 P 2 O 7 , 100 mM NaF, 1 mM Na 3 VO 4 ) containing Complete protease inhibitors and the lysate clarified by centrifugation at 13,500 rpm at 4°C for 10 min. Clarified lysates were incubated with antibodies as described above and 50 µl 20% (v/v) protein G-Sepharose or protein A-Sepharose (Sigma) at 4°C with gentle rotation for 90 min. Immune complexes were washed three times with 1 ml NP-40 lysis buffer, bound proteins eluted by boiling for 5 min in reducing SDS-Laemmli sample buffer and resolved by SDS-PAGE. Proteins were electrophoretically transferred to Immobilon-P membrane (Millipore), and incubated in a blocking solution of 5% non-fat skim milk powder (w/v) in TBST (20 mM Tris-Base pH 7.5, 150 mM NaCl, 0.05% (v/v) Tween-20) or in 1% BSA (w/v) in TBST (for anti-phosphotyrosine western blotting) for a minimum of 1 h prior to addition of antibody for 1 h at room temperature. Membranes were washed three times in TBST and incubated at room temperature for 1 h with an appropriate secondary antibody conjugated to horseradish peroxidase. Following incubation with secondary antibodies, membranes were washed three times in TBST and developed using enhanced chemiluminescence (Amersham) according to the manufacturer's instructions.
In vitro binding experiments
The lysate of 2 × 10 7 Jurkat T cell equivalents was prepared as described above, and incubated with approximately 5 µg GST fusion protein coupled to glutathione-sepharose 4B beads for 90 min at 4°C. The beads were washed three times with NP-40 lysis buffer, resuspended in reducing SDS-Laemmli sample buffer, the proteins resolved by SDS-PAGE and transferred to Immobilon-P membrane. Western blotting and detection of immunoreactive bands was carried out as described above.
